Cristina Mayor-Ruiz: A luminary in the fight against cancer
In a world where illness threatens life, brilliant minds emerge to illuminate the path to hope. Cristina Mayor-Ruiz, a renowned young researcher, stands as a beacon in the fight against cancer, guiding humanity towards new innovative treatments.
An exceptional academic trip
Cristina’s journey began in Soria, Spain, where her passion for science was ignited at an early age. With an honors degree in Biotechnology and an Extraordinary Doctorate Award, her academic brilliance laid the foundation for her future achievements.
Discovering new frontiers in cancer treatment
Cristina’s work focuses on drug discovery through the targeted degradation of proteins, a revolutionary approach that opens new possibilities to attack previously unattainable therapeutic targets. Her research aims to overcome resistance to traditional therapies and provide hope to vulnerable patients, including children fighting cancer.
International recognition and support
Cristina’s exceptional talent has been recognized internationally. She has received prestigious fellowships from the European Molecular Biology Organization (EMBO) and Marie Curie, allowing her to conduct cutting-edge research in Vienna, Austria. Furthermore, she has obtained more than two million euros in financing for her projects, which demonstrates the importance of her work.
Other promising young researchers
Cristina is not alone in her search for medical advances. Along with her, a group of young researchers has received second prizes for her exceptional contributions to biomedical research.
Arnau Busquets: Pioneer in neuroscience and cannabinoid drugs
Arnau Busquets, from the Hospital del Mar Research Institute, has made significant advances in neuroscience and cannabinoid drugs. His work on a new therapeutic target for fragile X syndrome has led to a patent and the development of new drugs that are currently being tested in patients with Down syndrome.
Pilar Domingo: Biomedical innovation with phages
Pilar Domingo, from the Institute of Integrative Systems Biology (i2SysBio), has used phages as biomedical tools to combat resistant bacteria. Her translational focus and outreach efforts have been recognized by the jury.
Bruno David Lourenço: Excellence in hematology and monoclonal gammopathies
Bruno David Lourenço, from the Clínica Universidad de Navarra, has carried out outstanding research in hematology and monoclonal gammopathies, focusing on multiple myeloma. His comprehensive research profile and his ability to obtain funding and collaborate with companies have made him a promising researcher.
Alfonso de Oyarzábal: Searching for cures for neurodevelopmental diseases
Alfonso de Oyarzábal, from the Sant Joan de Déu Hospital in Barcelona, has dedicated his research to finding pharmacological treatments for neurodevelopmental diseases, many of them rare. His work has led to several clinical trials in pediatric diseases such as Rett syndrome.
A bright future for biomedical research
The Farmaindustria Young Researchers Award is a testament to the association’s commitment to the future of biomedical research in Spain. The laureates and runners-up represent the next generation of scientists who are pushing the boundaries of medicine and paving the way for a healthier future for all.
A jury of experts
The jury responsible for selecting the winners was made up of prominent professionals from the scientific community, including representatives of research institutions and medical organizations. Their experience and knowledge ensured a rigorous and fair evaluation process.
A sample of Spanish excellence
The large number of high-quality applications received from all regions of Spain is a testament to the country’s vibrant biomedical research community. The diversity of the projects presented reflects the wide range of research underway in Spain, from drug discovery to the development of new therapies.
A commitment to the future
The Farmaindustria Young Researchers Award is more than a recognition of individual achievements. It is an investment in the future of biomedical research in Spain. By supporting promising young researchers, the association is sowing the seeds of new discoveries and advances that will improve the health and well-being of generations to come.
